Lv1
40 积分 2025-01-22 加入
Comparison of the prognostic effect of taxane regimens combined with ramucirumab before nivolumab for advanced gastric cancer
2天前
已完结
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
19天前
已完结
Myeloid subsets impede the efficacy of anti-PD1 therapy in patients with advanced gastric cancer (WJOG10417GTR study)
30天前
已完结
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort
1个月前
已完结
Survival outcomes of patients with gastric cancer treated with first-line nivolumab plus chemotherapy based on claudin 18.2 expression
1个月前
已完结
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
1个月前
已完结
Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
2个月前
已完结
Efficacy and safety of different drugs in patients with HER2-positive gastric cancer: network meta-analysis
2个月前
已完结
Robotic Technology in Emergency General Surgery Cases in the Era of Minimally Invasive Surgery
2个月前
已完结
National trends and outcomes of robotic emergency general surgery in the United States
2个月前
已完结
皖公网安备34019202002308
